SCOPE Europe 2024
Talk
Use Case: From Theory to Therapy—Accelerating Clinical Trials with AI
Wed, Oct 30, 2024 · 3:05–3:20 PM CET InterContinental Barcelona
About this session
Session: WEDNESDAY AFTERNOON PLENARY SESSION: NEW ERA OF RISK/QUALITY (R3) & LEVERAGING AI TO ACCELERATE TRIALS
An exploration of the future potential of GenAI in clinical trials, focusing on optimising trial efficiency, reducing costs, and the broader business impact. Inspire the audience to think about the long-term benefits of integrating GenAI into their processes.
